Back to Search
Start Over
Unsupervised PrEP in routine practice: a new challenge?
- Source :
- International Journal of STD and AIDS, International Journal of STD and AIDS, SAGE Publications, 2019, 30 (7), pp.715-717. ⟨10.1177/0956462419828872⟩
- Publication Year :
- 2019
- Publisher :
- SAGE Publications, 2019.
-
Abstract
- International audience; Pre-exposure prophylaxis (PrEP) for the prevention of HIV infection with 300 mg daily tenofovir co-formulated with 200 mg emtricitabine is recommended as one prevention option for people who are at substantial risk of acquiring an HIV infection. We report the case of a 28-year-old man who has sex with men and who was referred to our unit for a primary HIV infection with positive p18, p24 and gp160 bands on Western blot analysis but with a low HIV plasma viral load. Although HIV misdiagnosis should always be considered in cases of atypical seroconversion pattern with a low viral burden, unsupervised PrEP should be systematically investigated.
- Subjects :
- Adult
Male
Tenofovir
Anti-HIV Agents
diagnosis
Human immunodeficiency virus (HIV)
HIV Infections
Dermatology
Routine practice
medicine.disease_cause
Emtricitabine
Primary HIV infection
Plasma viral load
03 medical and health sciences
0302 clinical medicine
medicine
Humans
Pharmacology (medical)
030212 general & internal medicine
Homosexuality, Male
Seroconversion
030505 public health
human immunodeficiency virus
treatment
business.industry
Prevention
sexual behaviour
Public Health, Environmental and Occupational Health
virus diseases
Viral Load
Virology
3. Good health
Infectious Diseases
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
HIV-1
Pre-Exposure Prophylaxis
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
0305 other medical science
business
Viral load
medicine.drug
Subjects
Details
- ISSN :
- 17581052 and 09564624
- Volume :
- 30
- Database :
- OpenAIRE
- Journal :
- International Journal of STD & AIDS
- Accession number :
- edsair.doi.dedup.....51cfad3c47de7b5b793c813a446f153c